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Ai~a'aet 
Calcium and its ubiquitous intraeellular receptor calmodulin are required for cell proliferation. Studies in a variety of model systems are beginning 
to identify components of the calcium/calmoduiin cascade requited for movement of quiescent cells into the cell cycle as well as for proliferating cells 
to move from G 1 to S, G2 to M and through mitosis. Two calcium/calmodulin-dependent enzymes, the multifunctional calcium/calmodulin-dependent 
protein kinase and the protein phosphatase 2B (calcineurin) as well as a spindle pole body protein that binds calmodulin in the absence of calcium 
have been shown to be essential at specific phases of the cell cycle. In addition, the status of the intraceUular calcium pools is critical for normal 
traverse of the cell cycle. 
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As one of the predominant intracellular second mes- 
sengers, it is little wonder that Ca 2÷ is involved in the 
regulation of cell proliferation. This ion and its primary 
receptor protein calmodulin are essential for cells to sur- 
vive and grow. Calcium and calmodulin have been impli- 
cated in the re-entry of quiescent cells into the prolifera- 
tive cycle as well as for traversing the GJS, G2/M and 
metaphase/anaphase boundaries of the cell cycle [1, 2]. 
However, because of the ubiquitous nature of this dy- 
namic duo, and the plethora of cellular events they regu- 
late, it has been difficult to ascribe to them anything 
more than a supporting or housekeeping role in mam- 
malian cell cycle regulation. In stark contrast, Ca 2+ is 
both the necessary and sufficient signal for resumption 
of meiosis in quiescent marine oocytes and eggs awaiting 
fertilization [2]. The frog egg, sea urchin egg and surf 
clam oocyte are arrested in meiotic metaphase, G~ (be- 
fore START) and (32, respectively. In these cases, a tran- 
sient increase in intracellular Ca 2+ is the physiological 
trigger used to initiate a cascade of events resulting in 
completion of meiosis and initiation of subsequent mi- 
totic divisions. 
Perhaps most is known regarding the role of Ca 2+ and 
calmodulin in Xenopus fertilization. The fully grown frog 
oocytes are arrested in prophase of meiosis I. Progester- 
one results in a release of this block and cells progress 
through meiosis I to metaphase of meiosis II where they 
again arrest. Sperm entry normally awakens these quies- 
cent eggs and the primary regulatory event is the release 
of Ca 2+ from intracellular stores. The original block in 
prophase of meiosis I is due to formation of a protein 
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complex called Cytostatic Factor or CSF. Paradoxically 
this complex includes the protooncogene c-mos, a pro- 
tein kinase that is involved earlier in the pathway in the 
activation of Maturation Promoting Factor (MPF). 
MPF is composed of the p34 cd~ protein kinase and its 
regulatory cyclin BI subunit and is required for the 
breakdown of the germinal vesicle membrane (GVBD). 
Following GVBD, the MPF is also required for the pro- 
gression of meiosis and, upon arrest at metaphase of the 
second meiotic division, both MPF and CSF are active. 
Thus fertilization and the requisite Ca 2+ increase, must 
inactivate both CSF and MPF in order for meiosis to 
resume. 
A variety of microinjection experiments have been 
used to evaluate the temporal sequence of events et into 
play by the Ca 2+ transients. Microinjection of Ca 2+, ino- 
sitol-l,4,5-trisphosphate (IP3), and Ca2+/calmodulin 
were shown to activate whereas anticalmodulin drugs, 
calmodulin binding peptides and c-mos were found to be 
inhibitors of the Ca 2+ signal [2]. Subsequent to the Ca 2+ 
signal and formation of Ca2+/calmodulin, various inves- 
tigators showed destruction of cyclic B1 and c-mos, as 
well as inactivation of CSF measured by the ability of an 
oocyte xtract o induce meiotic arrest [3-5]. Since it was 
clear that a Ca2+/calmodulin pathway was involved, the 
question was to identify the relevant Ca2+/calmodulin 
target protein. This was accomplished by Lorca et al. [6] 
who took advantage of reagents made possible due to the 
molecular understanding of the anatomy of calmodulin- 
dependent protein kinases. 
Calmodulin-dependent kinases composed of a single 
polypeptide chain are inactive in the absence of Ca2+/ 
calmodulin. This inhibition is due to a portion of the 
protein assuming a conformation that prevents access of 
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the protein substrate and has been termed intrasteric 
inhibition [7,8]. This autoinhibitory egion is contiguous 
or overlapping with the Ca2+/calmodulin binding region. 
Binding of Ca2+/calmodulin results in relief of this auto- 
inhibition and allows pbosphorylation f substrate pro- 
teins. Because of this anatomy, it has been possible to 
create three biological peptidic reagents each with a 
unique property. These three reagents are: (i) a Ca2+/ 
caimodulin binding peptide [9]; (ii) a constitutively active 
enzyme created by deletion of the autoregulatory domain 
[10]; and (iii) a peptide analog of the autoinhibitory re- 
gion that does not bind Ca2÷/calmodulin but will serve 
as a competitive inhibitor of the enzyme [11,12]. Lorca 
et al. [5] first showed that a Ca2+/calmodulin binding 
peptide based on the corresponding region of smooth 
muscle myosin light chain kinase would prevent the Ca 2+ 
induced activation of Xenopus eggs. This arrest could be 
overcome by the co-injection of a constitutively active 
form of a Ca2+/calmodulin-dependent protein ldnase IIo~ 
(CaM kinase IIct) [6]. Finally the effect of this fragment 
of CaM kinase II,t could be prevented by co-injection of 
the synthetic peptide based on the autoinhibitory se- 
quence of this enzyme. Confirmation that a CaM kinase 
II-like enzyme represents the relevant Ca2+/calmodulin 
target in vivo came from the demonstration that Ca 2÷ 
caused the rapid activation of a kinase in the egg that: 
(a) phosphorylated a known peptide substrate of CaM 
kinase II; (b) was inhibited by the Ca2+/calmodulin bind- 
ing peptide; and (c) was inhibited by the autoinhibitory 
peptide but not by another peptide based on the autoin- 
hibitory region of protein ldnase C [6]. 
Even though Lorca et al. [6] presented compelling ev- 
idence that CaM kinase mediates the Ca2÷/calmodulin 
stimulation of the resumption of meiosis in Xenopus 
eggs, the nature of the immediate downstream target of 
this kinase is unclear. Inactivation of CSF seems to be 
secondary to the destruction of cyclin B1 which also sig- 
nals the inactivation of MPF [3]. Cyclin B1 is rapidly 
proteolyzed following ubiquitination [13]. Thus a logical 
target for CaM kinase II would be a rate limiting compo- 
nent of the ATP-dependent ubiquitin protein cascade. 
Surely the frog egg system is a good one in which to 
evaluate this possibility. 
Additional evidence in a variety of experimental sys- 
tems also suggests a role for a CaM kinase in G2/M 
progression. Baitinger et al. [14] have reported that this 
enzyme mediates the Ca2+/calmodulin requirement for 
nuclear envelope breakdown that is required for resump- 
tion of meiosis following fertilization of sea urchin eggs. 
Planas-Silva nd Means [15] revealed that inducible ex- 
pression of a constitutively active form of CaM kinase 
II~ in a mouse cell line resulted in a G2 arrest. These 
observations imply that not only is a CaM kinase-de- 
pendent phosphorylation event(s) required for GflM 
progression but this substrate(s) must also be 
dephosphorylated for entry into mitosis to occur. 
Creation of a strain of the filamentous fungus Asper- 
gillus nidulans that is conditional for the expression of 
calmodulin, not only was used to show that the unique 
calmodulin gene was essential, but also that Ca 2÷ and 
calmodulin are required for spores to re-enter the prolif- 
erative pathway (Go reentry), G~/S, G2/M and metaphase 
of mitosis [16]. The latter two arrest points are consistent 
with the results in the marine egg systems described pre- 
viously (i.e. Xenopus and sea urchin) and raised the ques- 
tion of whether CaM kinase might also mediate the pro- 
gression into and exit from mitosis in Aspergillus. The 
Aspergillus CaM kinase was first purified by Barter et 
al. [17] and the eDNA was cloned and sequenced by the 
same laboratory [18]. Although a monomer and only 
29% identical to mammalian CaM kinase II0t, it phos- 
phorylates many of the same substrates in vitro. We have 
found this gene to be unique and essential and overex- 
pression of a constitutively active form in exponentially 
growing cells arrests cells in (32. At the (32 arrest point 
caused when calmodulin (or Ca 2+) levels are held low, 
two protein kinases that are essential for the G2/M tran- 
sition in Aspergillus are inactive [19]. These kinases are 
p34 cd~2 which remains tyrosine phosphorylated and 
NIMA, a Ser/Thr specific protein kinase that requires 
phosphorylation on Ser/Thr residues to exhibit activity 
[20], and is now known to have a homolog in mammalian 
cells [21], Preliminary experiments in our laboratory sug- 
gest that CaM kinase may be involved in activation of 
both enzymes. The Aspergillus CaM kinase will phos- 
phorylate and restore some activity in vitro to bacterially 
expressed, ephosphorylated and inactive NIMA. Cal- 
modulin kinase will also phosphorylate NIMT which is 
the homolog of cdc25, the tyrosine phosphatase that 
dephosphorylates and thereby activates p34 ca~. Patel et 
al. [22] have also reported that mammalian CaM kinase 
II~ will phosphorylate the human cdc25 homolog 
(p54 ~¢25n) and that this phosphorylation increases phos- 
phatase activity by several fold. Thus CaM kinase may 
be a primary mediator of the requirement for Ca2+/cal - 
modulin both for entry into and exit from mitosis. 
Whereas CaM kinase is likely to be important in medi- 
ating the Ca2+/calmodulin requirement for the G2/M 
transition and the metaphase anaphase transition, other 
targets for calmodulin clearly exist. In the budding yeast 
Saccharomyces cerevisiae, the calmodulin gene CMD 1 is 
also unique and essential [23]. However, at least two 
CaM kinase genes exist in this organism and even when 
both genes are deleted, no obvious phenotypc was ob- 
served [24,25]. At least two of the essential functions of 
calmodulin in yeast are chromosome s gregation and the 
polarized growth required for bud formation [26,27]. 
The unexpected finding made by Geise et al. [28] was 
that these essential functions of calmodulin were inde- 
pendent of Ca 2÷ binding. In an elegant series of experi- 
ments Geiser et al. [29] identified the essential mitotic 
target of calmodulin as the 100-kDa component of the 
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spindle pole body called Nuflp or SPC110. This interac- 
tion does not require Ca 2÷ and calmodulin/Nuflp are 
co-localized to the spindle pole body in yeast cells. Re- 
cently Sprang et al. [30] have identified the product of the 
CDC31 gene also to be a component of the spindle pole 
body in yeast. This gene is also essential and encodes a
161 amino acid Ca 2÷ binding protein with a striking 
homeology to calmodulin. Since the spindle pole body in 
budding yeast is homologous to the centromere of mam- 
malian cells and since calmodulin is localized to the spin- 
dle poles throughout mitosis in mammalian cell [31], it 
is probable that essential mitotic functions for calmod- 
ulin exist in other species that are also independent of 
Ca 2÷ and presumably not related to a enzyme regulatory 
role. Examination of this possibility in other genetically 
tractable systems in which calmodulin is essential should 
prove illuminating. 
On the other hand other essential functions for cal- 
modulin in yeast remain to be discovered. Ohya and 
Botstein [32] have individually mutated the phenylalan- 
ine residues in the CMD 1 gene and selected temperature 
sensitive phenotypes for evaluation. The mutations were 
classified into four complementation groups affecting 
actin or calmodulin organization, nuclear division or 
bud emergence. Interestingly all mutations affecting 
calmodulin localization and bud emergence were located 
in the NH2-terminal half of the protein, whereas actin 
organization or bud emergence phenotypes tracked to 
the COOH-terminal half. Whether these functions of 
calmodulin require Ca 2÷ binding and identification of the 
respective targets, remain to be determined. 
Calcium and calmodulin are also required for quies- 
cent cells to re-enter the cell cycle in response to a mito- 
gen and at the GI/S boundary where the concentration 
of calmodulin is controlled [1]. Considerably less is 
known regarding relevant arget proteins for Ca2÷/cal - 
modulin at these critical progression control points. Cal- 
modulin kinase has been implicated in the re-entry path- 
way as it will phosphorylate the CREB transcription 
factor and regulate expression of immediate arly re- 
sponse genes uch as the protooncogene c-fos [33]. It has 
also been reported that the quite selective pharmacologi- 
cal inhibitor of CaM kinase, KN-93 [34], will prevent 
quiescent ws-1 human fibroblasts from reaching S phase 
upon serum stimulation [35]. Since some cellular events 
that occur in Go are unique to this phase of the cell cycle, 
there is no reason to exclude CaM kinase as a component 
of the regulatory cascade that signals Go. However, it is 
possible that the multifunctional CaM kinases may not 
prove to be as critical for the progression from mitosis 
to DNA synthesis. Preliminary data suggest hat addi- 
tion of KN-93 will specifically arrest exponentially grow- 
ing HeLa cells in G2 (C. Rasmussen, personal communi- 
cation). In Aspergillus, CaM kinase appears to be re- 
quired for spores to initiate DNA synthesis upon germi- 
nation and for G2 progression but not for the movement 
of cells through G~. In the fungal system, it seems prob- 
able that one relevant Ca2+/CaM target required for the 
G~/S transition is the protein Ser/Thr phosphatase 2B 
known as calcineurin. The catalytic subunit gene of this 
enzyme has been cloned shown to be unique and essen- 
tial [36]. In the absence of calcineurin A, cells arrest early 
in the cell cycle, most likely in G1. This observation is
consistent with studies in other systems in which cal- 
cineurin is required for growth and could act early in the 
cell cycle. Three genes encoding calcineurin subunits, 2A 
and 1 B, have been cloned from budding yeast. Whereas 
deletion of all three genes in the same strain was not 
lethal, such cells cannot survive 0~ factor, which normally 
arrests cell before START [37]. It has also been reported 
that calcineurin A mediates inhibition of recovery from 
0~ factor arrest resulting from treatment of cells with the 
immunosuppressive drugs FK-506 and cyclosporin A 
[38]. As calcineurin is the primary intracellular target for 
these drugs when associated with their respective binding 
proteins, it follows that this phosphatase is required for 
resumption of growth in yeast. Finally, calcineurin is 
known to be involved in the cascade of events triggered 
by activation of the T-cell receptor on quiescent lympho- 
cytes [39]. This enzyme is normally responsible for 
dephosphorylation f a component of the NFAT tran- 
scription factor. NFAT and other transcription factors 
are required to activate genes encoding lymphokines 
such as IL-2 which are involved in initiation of cell cycle 
progression. Thus, in organisms as diverse as budding 
yeast, filamentous fungus and mammalian cells, a case 
can be made for a calcineurin requirement in G0/Gt. 
It should be mentioned that Ca 2+ and intraceUular 
Ca 2+ pools may also play important roles in cell prolifer- 
ation independent ofcalmodulin. For example depletion 
of the IP 3 sensitive intracellular Ca 2* pool with pharma- 
cological inhibitors such as thapsigargin, results in cell 
cycle arrest [40]. We have shown that G0/G 1 and S phases 
are sensitive to pool depletion whereas G2 and M are not. 
These growth inhibitory effects are independent of intra- 
cellular free Ca 2+ levels and remarkably, pool depletion 
at any sensitive portion of the cell cycle resets the cell 
cycle to a state very similar to Go. Pool depletion also 
activates a capacitive Ca 2÷ entry pathway through a sub- 
set of plasma membrane associated Ca 2÷ channels [41], 
about which nothing is known biochemically. Preventing 
Ca 2÷ entry via this pathway arrests cells in G2 or M even 
though such cells are not affected by intracellular pool 
depletion. This entire area is only now becoming appre- 
ciated and will be an important component of Ca 2+ 
research in the future. These few observations illus- 
trate how complicated the Ca 2÷ field has become but also 
how important unraveling these mechanism will be to 
gain a solid appreciation of the multiple roles played by 
Ca 2÷, calmodulin and the components hat control intra- 
cellular Ca 2÷ homeostasis in regulation of cell prolifera- 
tion. 
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